The mechanism of phospholipase Cγ1 activation
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2011, Vol 65, Issue 0
Abstract
Phospholipase C is an enzyme which catalyzes the hydrolysis of phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) into second messengers inositol-1,4,5-triphosphate (Ins(1,4,5)P3) and diacylglycerol (DAG). These messengers then promote the activation of protein kinase C and release of Ca2+ from intracellular stores, initiating numerous cellular events including proliferation, differentiation, signal transduction, endocytosis, cytoskeletal reorganization or activation of ion channels. There have been identified 14 isozymes of PLC among which PLCγ1 and PLCγ2 are of particular interest. PLC contains catalytic region XY and a few regulatory domains: PH, EF and C2. The most unique features of these two enzymes are the Src homology domains (SH2, SH3) and split PH domain within the catalytic barrel. PLC1 and PLCγ2 have an identical domain structure, but they differ in their function and occurrence. Phospholipase Cγ1 is expressed ubiquitously, especially in the brain, thymus and lungs. PLCγ1 can be activated by receptor tyrosine kinases (i.e.: PDGFR, EGFR, FGFR, Trk), as well as non-receptor protein kinases (Src, Syk, Tec) or phosphatidic acid, tau protein and its analogue. The molecular mechanism of PLCγ1 activation includes membrane recruitment, phosphorylation, rearrangements and activation in the presence of growth factors. In reference to PLCγ1 regulation, a number of positive and negative modulators have been considered. The most important positive modulator is phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P2). Protein kinase A and C, tyrosine phosphatases (SHP-1, PTP-1B) and Cbl, Grb2, Jak2/PTP-1B complex proteins have been described as negative regulators of PLCγ1 activation.
Authors and Affiliations
Paweł Krawczyk, Janusz Matuszyk
Keywords
Related Articles
- EP ID EP66509
- DOI -
- Views 156
- Downloads 0
Rola profilowania genowego z zastosowaniem macierzy DNA w diagnostyce, określaniu rokowania i odpowiedzi na leczenie w raku jelita grubego
Rak jelita grubego to najczęstszy nowotwór przewodu pokarmowego. Nowotwór ten rozpatrywany jest jako biologiczny model kancerogenezy, w którego przemianie od wczesnego do późnego gruczolaka, a następnie do późnego raka...
Cell reactions and immune responses to photodynamic therapy in oncology
Photodynamic therapy (PDT) is a noninvasive, highly selective method for the treatment of diseases characterized by uncontrolled cell proliferation. It was clinically approved more than 30 years ago. PDT involves the sel...
Mechanisms of endocytosis utilized by viruses during infection
Viruses, despite being relatively simple in structure and composition, have evolved a broad spectrum of mechanisms to exploit the host cell. To initiate effective infection, viruses or viral genomes have to enter cells....
Wpływ propofolu na parametry stanu oksydacyjno-antyoksydacyjnego narządów obwodowych w modelu doświadczalnym u szczurów z chorobą Parkinsona
Analiza zakażeń wywołanych przez Clostridium difficile u chorych hospitalizowanych na oddziale nefrologicznym w Polsce